237 related articles for article (PubMed ID: 28723231)
1. Fear of Cancer Recurrence in an Era of Personalized Medicine.
Thewes B; Husson O; Poort H; Custers JAE; Butow PN; McLachlan SA; Prins JB
J Clin Oncol; 2017 Oct; 35(29):3275-3278. PubMed ID: 28723231
[No Abstract] [Full Text] [Related]
2. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
3. Advancing shared decision making for symptom monitoring in people living beyond cancer.
Heathcote LC; Goldberg DS; Eccleston C; Spunt SL; Simons LE; Sharpe L; Earp BD
Lancet Oncol; 2018 Oct; 19(10):e556-e563. PubMed ID: 30303128
[TBL] [Abstract][Full Text] [Related]
4. Banter.
McNeil CM
J Clin Oncol; 2017 Oct; 35(28):3262-3263. PubMed ID: 28806118
[No Abstract] [Full Text] [Related]
5. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM; Mansfield E; Pazdur R
JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
[No Abstract] [Full Text] [Related]
6. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
7. Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients.
Puzzoni M; Ziranu P; Demurtas L; Lai E; Mariani S; Liscia N; Soro P; Pretta A; Impera V; Camera S; Musio F; Persano M; Donisi C; Tolu S; Balconi F; Scartozzi M
Future Oncol; 2020 Jan; 16(2):4337-4339. PubMed ID: 31793396
[No Abstract] [Full Text] [Related]
8. Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study.
Tomei C; Lebel S; Maheu C; Lefebvre M; Harris C
Support Care Cancer; 2018 Aug; 26(8):2751-2762. PubMed ID: 29500582
[TBL] [Abstract][Full Text] [Related]
9. New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy.
Bao J; Qiao L
Cancer Lett; 2017 Feb; 387():1-2. PubMed ID: 28038727
[No Abstract] [Full Text] [Related]
10. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
Horlings HM; Shah SP; Huntsman DG
JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
[No Abstract] [Full Text] [Related]
11. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
12. Maurie Markman on the Groundbreaking TAPUR Trial.
Markman M
Oncology (Williston Park); 2017 Mar; 31(3):158, 168. PubMed ID: 28299751
[No Abstract] [Full Text] [Related]
13. Regret and fear in prostate cancer: The relationship between treatment appraisals and fear of recurrence in prostate cancer survivors.
Maguire R; Hanly P; Drummond FJ; Gavin A; Sharp L
Psychooncology; 2017 Nov; 26(11):1825-1831. PubMed ID: 28124398
[TBL] [Abstract][Full Text] [Related]
14. Is Precision Medicine an Oxymoron?
Eckhardt SG; Lieu C
JAMA Oncol; 2019 Feb; 5(2):142-143. PubMed ID: 30419105
[No Abstract] [Full Text] [Related]
15. Moderating effects of perceived growth on the association between fear of cancer recurrence and health-related quality of life among adolescent and young adult cancer survivors.
Cho D; Park CL
J Psychosoc Oncol; 2017; 35(2):148-165. PubMed ID: 27749160
[TBL] [Abstract][Full Text] [Related]
16. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
17. A correlation study of fear of cancer recurrence, illness representation, self-regulation, and quality of life among gynecologic cancer survivors in Taiwan.
Tsai LY; Lee SC; Wang KL; Tsay SL; Tsai JM
Taiwan J Obstet Gynecol; 2018 Dec; 57(6):846-852. PubMed ID: 30545539
[TBL] [Abstract][Full Text] [Related]
18. The course of fear of cancer recurrence: Different patterns by age in breast cancer survivors.
Starreveld DEJ; Markovitz SE; van Breukelen G; Peters ML
Psychooncology; 2018 Jan; 27(1):295-301. PubMed ID: 28727897
[TBL] [Abstract][Full Text] [Related]
19. Fear of cancer recurrence and its predictors among cervical cancer survivors.
Hanprasertpong J; Geater A; Jiamset I; Padungkul L; Hirunkajonpan P; Songhong N
J Gynecol Oncol; 2017 Nov; 28(6):e72. PubMed ID: 28758378
[TBL] [Abstract][Full Text] [Related]
20. Fear of Progression in Cancer Patients and Survivors.
Dinkel A; Herschbach P
Recent Results Cancer Res; 2018; 210():13-33. PubMed ID: 28924677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
